Loss of enzymatic activity of MGMT is correlated with prolonged survival of patients affected by glioblastoma that received temozolomide treatment; in fact this mechanism is a valid help to induce, by using temozolomide, DNA damage in glioblastoma with consequent cellular death. This evidence concerns the gene MGMT and glioblastoma.